HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rosette Lidereau Selected Research

Therapeutics

10/2009Large-scale real-time reverse transcription-PCR approach of angiogenic pathways in human transitional cell carcinoma of the bladder: identification of VEGFA as a major independent prognostic marker.
2/2009Identification of TACC1, NOV, and PTTG1 as new candidate genes associated with endocrine therapy resistance in breast cancer.
10/2008mTOR inhibition reverses acquired endocrine therapy resistance of breast cancer cells at the cell proliferation and gene-expression levels.
3/2008ABCC11 expression is regulated by estrogen in MCF7 cells, correlated with estrogen receptor alpha expression in postmenopausal breast tumors and overexpressed in tamoxifen-resistant breast cancer cells.
12/2007The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy.
6/2006Is quantitative real-time RT-PCR an adjunct to immunohistochemistry for the evaluation of ErbB2 status in transitional carcinoma of the bladder?
12/2005[Anti-ErbB targeted therapy and urothelial tumors].
4/2003Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rosette Lidereau Research Topics

Disease

51Breast Neoplasms (Breast Cancer)
01/2023 - 03/2002
46Neoplasms (Cancer)
01/2021 - 03/2002
14Carcinogenesis
01/2020 - 03/2002
12Neoplasm Metastasis (Metastasis)
01/2021 - 01/2007
3Carcinoma (Carcinomatosis)
07/2015 - 04/2003
3Urinary Bladder Neoplasms (Bladder Cancer)
06/2013 - 04/2003
2Triple Negative Breast Neoplasms
10/2023 - 01/2012
2Ovarian Neoplasms (Ovarian Cancer)
10/2021 - 01/2012
2Inflammatory Breast Neoplasms
10/2013 - 02/2008
2Melanoma (Melanoma, Malignant)
10/2011 - 09/2007
2Transitional Cell Carcinoma
06/2006 - 03/2006
1Squamous Cell Carcinoma of Head and Neck
07/2016
1Non-Muscle Invasive Bladder Neoplasms
06/2013
1Kidney Neoplasms (Kidney Cancer)
10/2011
1Hypoxia (Hypoxemia)
10/2011
1Poikiloderma of Kindler
09/2011
1Atrophy
09/2011
1Inborn Genetic Diseases (Disease, Hereditary)
09/2011
1Brain Neoplasms (Brain Tumor)
08/2011
1Starvation
07/2011
1Tetraploidy
02/2011
1Aneuploidy (Aneuploid)
02/2011

Drug/Important Bio-Agent (IBA)

25Messenger RNA (mRNA)IBA
01/2020 - 03/2002
17Proteins (Proteins, Gene)FDA Link
01/2020 - 09/2002
12Estrogen Receptor alphaIBA
12/2010 - 04/2003
9Estrogens (Estrogen)FDA Link
01/2012 - 03/2002
7TamoxifenFDA LinkGeneric
02/2009 - 04/2003
6Protein Isoforms (Isoforms)IBA
11/2018 - 07/2004
6Estrogen ReceptorsIBA
07/2015 - 03/2002
5DNA (Deoxyribonucleic Acid)IBA
01/2023 - 10/2003
5Hormones (Hormone)IBA
07/2015 - 03/2002
4RNA (Ribonucleic Acid)IBA
01/2020 - 01/2007
4Biomarkers (Surrogate Marker)IBA
01/2020 - 08/2012
4MicroRNAs (MicroRNA)IBA
07/2015 - 05/2011
4RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
10/2010 - 03/2002
3AnthracyclinesIBA
10/2023 - 12/2007
3Phenobarbital (Luminal)FDA Link
01/2021 - 01/2009
3Estradiol (Delestrogen)FDA LinkGeneric
07/2015 - 02/2008
3LigandsIBA
07/2006 - 09/2003
3EnzymesIBA
01/2004 - 04/2003
2WW Domain-Containing OxidoreductaseIBA
10/2018 - 05/2015
2VimentinIBA
01/2013 - 09/2007
2AntigensIBA
10/2009 - 09/2007
2ATP-Binding Cassette Transporters (ABC Transporters)IBA
03/2008 - 01/2004
2NF-kappa B (NF-kB)IBA
02/2008 - 12/2007
2Toll-Like Receptor 4IBA
12/2007 - 09/2007
2Immunologic Adjuvants (Immunologic Adjuvant)IBA
12/2007 - 09/2007
2Neoplasm Antigens (Tumor Antigens)IBA
12/2007 - 09/2007
2HMGB1 Protein (HMG1)IBA
12/2007 - 09/2007
2Steroid Receptors (Steroid Receptor)IBA
11/2005 - 04/2003
2Estrogen Receptor betaIBA
11/2004 - 07/2004
2Neuregulin-1 (Neuregulin 1)IBA
03/2004 - 09/2003
2Estrogen Receptor Modulators (Antiestrogen)IBA
01/2004 - 03/2002
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2023
1Poly(ADP-ribose) Polymerase InhibitorsIBA
10/2021
1N-(2-naphthalene)sulfonyl-DL-tryptophan (A 91)IBA
01/2021
1Forkhead Box Protein O1IBA
01/2020
1Forkhead Box Protein O3IBA
01/2020
1PhosphopeptidesIBA
01/2019
1Apoptosis Regulatory ProteinsIBA
10/2018
1Toll-Like Receptors (Toll-Like Receptor)IBA
12/2016
1Pattern Recognition ReceptorsIBA
12/2016
1Toll-Like Receptor 9IBA
12/2016
1Long Noncoding RNAIBA
01/2016
1Tumor Suppressor Protein p14ARF (p14ARF)IBA
01/2016
1CateninsIBA
05/2015
1Poly Adenosine Diphosphate RiboseIBA
12/2013
1ADP-ribosylarginine hydrolaseIBA
12/2013
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
12/2013
1Poly (ADP-Ribose) Polymerase-1IBA
12/2013
1HydrolasesIBA
12/2013
1poly ADP-ribose glycohydrolaseIBA
12/2013
1PolymersIBA
12/2013
170-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA
11/2013
1AntibodiesIBA
01/2013
1ChromatinIBA
11/2012
1Histones (Histone)IBA
11/2012
1Oxygen (Dioxygen)IBA
11/2012
1RNA Splicing FactorsIBA
11/2012
1RNA Helicases (RNA Helicase)IBA
11/2012
1Progesterone Receptors (Progesterone Receptor)IBA
01/2012
1imidazole mustard (BIC)IBA
01/2012
1Mutant Proteins (Protein, Mutant)IBA
10/2011
1Microphthalmia-Associated Transcription FactorIBA
10/2011
1Collagen Type I (Type I Collagen)IBA
09/2011
1IntegrinsIBA
09/2011
1matrigelIBA
09/2011
1glucose-regulated proteinsIBA
08/2011
1Inhibins (Inhibin)IBA
08/2011
1Doxorubicin (Adriamycin)FDA LinkGeneric
07/2011
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2011
1PlasminogenIBA
07/2011
1Annexin A5IBA
07/2011
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
07/2011
1BRCA1 ProteinIBA
05/2011
1Aurora Kinase AIBA
02/2011
1Keratins (Keratin)IBA
02/2011

Therapy/Procedure

8Therapeutics
10/2009 - 04/2003
4Drug Therapy (Chemotherapy)
10/2009 - 09/2007
2Radiotherapy
12/2007 - 09/2007